Author： Addeo Raffaele Zappavigna Silvia Luce Amalia Facchini Sergio Caraglia Michele
Publisher： Informa Healthcare
ISSN： 1474-0338
Source： Expert Opinion on Drug Safety, Vol.12, Iss.5, 2013-09, pp. : 729-740
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Targeting Angiogenesis for Treatment of NSCLC Brain Metastases
Current Cancer Drug Targets, Vol. 12, Iss. 3, 2012-03 ,pp. :
Access to resources
Recommend
The Role of Selective Lymphadenectomy in the Management of Patients with Malignant Melanoma
By GLASS L. FRANK FENSKE NEIL A. MESSINA JANE L. CRUSE C. WAYNE RAPAPORT DAVID P. BERMAN CLAUDIA PULEO C.A. HELLER RICHARD MILIOTES G. ALBERTINI J. REINTGEN DOUGLAS S.
Dermatologic Surgery, Vol. 21, Iss. 11, 1995-11 ,pp. :
Fotemustine active in disseminated malignant melanoma
Inpharma, Vol. 1, Iss. 1434, 2004-01 ,pp. :
The Role of Angiogenesis Inhibitors in the Management of Melanoma
Current Topics in Medicinal Chemistry, Vol. 12, Iss. 1, 2012-01 ,pp. :